• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Clin Microbiol Infect. Risk factors for disease severity, unimprovement, and mortality of COVID-19 patients in Wuhan, China

tetano

Editor, Senior Moderator
Clin Microbiol Infect. 2020 Apr 15. pii: S1198-743X(20)30217-2. doi: 10.1016/j.cmi.2020.04.012. [Epub ahead of print]
Risk factors for disease severity, unimprovement, and mortality of COVID-19 patients in Wuhan, China.


Zhang J[SUP]1[/SUP], Wang X[SUP]2[/SUP], Jia X[SUP]1[/SUP], Li J[SUP]1[/SUP], Hu K[SUP]3[/SUP], Chen G[SUP]3[/SUP], Wei J[SUP]4[/SUP], Gong Z[SUP]5[/SUP], Zhou C[SUP]6[/SUP], Yu H[SUP]1[/SUP], Yu M[SUP]2[/SUP], Lei H[SUP]7[/SUP], Cheng F[SUP]8[/SUP], Zhang B[SUP]9[/SUP], Xu Y[SUP]10[/SUP], Wang G[SUP]11[/SUP], Dong W[SUP]12[/SUP].

Author information




Abstract

OBJECTIVE:

Since December 2019, coronavirus disease (COVID-19) emerged in Wuhan. However, the characteristics and risk factors associated with disease severity, unimprovement and mortality are unclear.
METHODS:

All consecutive patients diagnosed with COVID-19 admitted to the Renmin Hospital of Wuhan University from January 11 to February 6, 2020 were enrolled in this retrospective cohort study.
RESULTS:

A total of 663 COVID-19 patients were included in this study. Among those, 247 (37.3%) had at least one kind of chronic disease. A total of 0.5% (n=3) of patients were diagnosed with mild COVID-19, while 37.8% (251/663), 47.5% (315/663), and 14.2% (94/663) were in moderate, severe, and critical condition, respectively. In our hospital during follow-up, 251 of 663 (37.9%) patients were improved and 25 patients died, leading to a mortality rate of 3.77%. Older patients (>60 years old) and those with chronic diseases were prone to have severe and critical COVID-19 conditions, show unimprovement, and die (P < 0.001, < 0.001). Multivariate logistic regression analysis identified being male (OR = 0.486, 95% CI 0.311-0.758; P = 0.001), having severe COVID-19 conditions (OR = 0.129, 95% CI 0.082-0.201; P < 0.001), expectoration (OR = 1.796, 95% CI 1.062-3.036; P = 0.029), muscle ache (OR = 0.309, 95% CI 0.153-0.626; P = 0.001), and decreased albumin (OR = 1.929, 95% CI 1.199-3.104; P = 0.007) were associated with unimprovement in COVID-19 patients.
CONCLUSION:

Being male, in severe COVID-19 conditions, expectoration, muscle ache, and decreased albumin were independent risk factors which influence the improvement of COVID-19 patients.
Copyright ? 2020 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.



PMID:32304745DOI:10.1016/j.cmi.2020.04.012
 
Back
Top Bottom